Trinity biotech announces strategic collaboration with medical artificial intelligence company pulseai

Dublin, ireland, may 16, 2024 (globe newswire) -- trinity biotech plc (nasdaq: trib) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence (“ai”) company pulseai to enhance the company's recently acquired continuous glucose monitor (cgm) biosensor technology.
TRIB Ratings Summary
TRIB Quant Ranking